Trial Profile
Comparison of insulin glargine and insulin degludec in type 2 diabetes by continuous glucose monitoring system
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary) ; Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 27 Nov 2013 Planned number of patients changed from 20 to 30 as reported by University Hospital Medical Information Network - Japan.
- 16 May 2013 New trial record